Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeline Pêtre

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Radiation Oncology|December 9, 2022
Salvage Involved-Field and Extended-Field Radiation Therapy in Positron Emission Tomography-Positive Nodal Recurrent Prostate Cancer: Outcomes and Patterns of FailureAdeline Pêtre, Magali Quivrin, Nathalie Briot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2025
Radiotherapy of skin cancersEmmanuelle Le Fur, Matthieu Pallandre, Adeline Pêtre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Benefit from adjuvant radiotherapy according to the number of risk factors in cutaneous squamous cell carcinomaAdeline Pêtre, Pascal Pommier, Tristan Brahmi, et al.
Oncotarget|May 19, 2018
Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME scheduleAdeline Pêtre, Cécile Dalban, Andy Karabajakian, et al.
Cancers|August 12, 2023
Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation TherapyEymeric Le Reun, Adeline Granzotto, Adeline Pêtre, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Radiation Oncology|December 9, 2022
Salvage Involved-Field and Extended-Field Radiation Therapy in Positron Emission Tomography-Positive Nodal Recurrent Prostate Cancer: Outcomes and Patterns of FailureAdeline Pêtre, Magali Quivrin, Nathalie Briot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2025
Radiotherapy of skin cancersEmmanuelle Le Fur, Matthieu Pallandre, Adeline Pêtre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Benefit from adjuvant radiotherapy according to the number of risk factors in cutaneous squamous cell carcinomaAdeline Pêtre, Pascal Pommier, Tristan Brahmi, et al.
Oncotarget|May 19, 2018
Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME scheduleAdeline Pêtre, Cécile Dalban, Andy Karabajakian, et al.
Cancers|August 12, 2023
Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation TherapyEymeric Le Reun, Adeline Granzotto, Adeline Pêtre, et al.
Pageof 1